HS
HighVista Strategies Portfolio holdings
AUM
$272M
This Quarter Return
+3.88%
1 Year Return
+24.34%
3 Year Return
+176.43%
5 Year Return
+271.23%
10 Year Return
+682.63%
AUM
$135M
AUM Growth
+$135M
(-14%)
Cap. Flow
-$27.9M
Cap. Flow
% of AUM
-20.74%
Top 10 Holdings %
Top 10 Hldgs %
55.15%
Holding
156
New
39
Increased
27
Reduced
28
Closed
31
Top Buys
| 1 |
MSDAU
MSD Acquisition Corp. Unit
MSDAU
|
$5.08M |
| 2 |
RP
RealPage, Inc.
RP
|
$3.37M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$3.29M |
| 4 |
WORK
Slack Technologies, Inc.
WORK
|
$3.28M |
| 5 |
Autohome
ATHM
|
$1.39M |
Top Sells
| 1 |
Dell
DELL
|
$28.7M |
| 2 |
TIF
Tiffany & Co.
TIF
|
$6.72M |
| 3 |
ACIA
Acacia Communications, Inc. Common Stock
ACIA
|
$3.24M |
| 4 |
FIT
Fitbit, Inc. Class A common stock
FIT
|
$3.07M |
| 5 |
Baidu
BIDU
|
$2.22M |
Sector Composition
| 1 | Technology | 31.89% |
| 2 | Healthcare | 28.92% |
| 3 | Financials | 8.63% |
| 4 | Consumer Discretionary | 6.74% |
| 5 | Communication Services | 4.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Black Diamond Therapeutics
BDTX
$161M
| $649K | 0.48% |
+26,770
| New | +$649K |
|
52
Altimmune
ALT
$324M
| $648K | 0.48% |
45,866
-26,512
| -37% | -$375K |
|
53
Adverum Biotechnologies
ADVM
$66.9M
| $640K | 0.48% |
64,906
+10,381
| +19% | +$102K |
|
54
Rocket Pharmaceuticals
RCKT
$351M
| $636K | 0.47% |
14,336
-10,231
| -42% | -$454K |
|
55
Travere Therapeutics
TVTX
$1.68B
| $615K | 0.46% |
+24,622
| New | +$615K |
|
56
ARS Pharmaceuticals
SPRY
$1.07B
| $614K | 0.46% |
+14,067
| New | +$614K |
|
|
NVTA
57
DELISTED
Invitae Corporation
NVTA
| $613K | 0.46% |
16,039
+626
| +4% | +$23.9K |
|
58
Novavax
NVAX
$1.23B
| $606K | 0.45% |
3,341
-2,381
| -42% | -$432K |
|
59
Nurix Therapeutics
NRIX
$701M
| $598K | 0.44% |
+19,222
| New | +$598K |
|
60
Athira Pharma
ATHA
$15.3M
| $590K | 0.44% |
32,062
| – | – |
|
61
Relay Therapeutics
RLAY
$678M
| $583K | 0.43% |
16,876
+1,901
| +13% | +$65.7K |
|
|
FMTX
62
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
| $578K | 0.43% |
20,630
+2,378
| +13% | +$66.6K |
|
63
Iovance Biotherapeutics
IOVA
$796M
| $575K | 0.43% |
18,163
-2,260
| -11% | -$71.5K |
|
64
Oric Pharmaceuticals
ORIC
$1.02B
| $547K | 0.41% |
+22,333
| New | +$547K |
|
|
CNST
65
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $544K | 0.4% |
23,271
-8,610
| -27% | -$201K |
|
66
Kymera Therapeutics
KYMR
$2.99B
| $542K | 0.4% |
13,941
-3,176
| -19% | -$123K |
|
67
Stoke Therapeutics
STOK
$1.09B
| $532K | 0.4% |
13,692
-3,976
| -23% | -$154K |
|
68
Rhythm Pharmaceuticals
RYTM
$6.85B
| $528K | 0.39% |
+24,809
| New | +$528K |
|
|
BCEL
69
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $526K | 0.39% |
34,301
+3,477
| +11% | +$53.3K |
|
70
Solid Biosciences
SLDB
$438M
| $506K | 0.38% |
+91,557
| New | +$506K |
|
71
Nkarta
NKTX
$150M
| $491K | 0.36% |
14,927
-9,061
| -38% | -$298K |
|
72
Olema Pharmaceuticals
OLMA
$426M
| $480K | 0.36% |
+14,455
| New | +$480K |
|
73
Acadia Pharmaceuticals
ACAD
$4.31B
| $428K | 0.32% |
16,590
+2,246
| +16% | +$57.9K |
|
74
Novo Nordisk
NVO
$252B
| $345K | 0.26% |
5,113
-2,582
| -34% | -$174K |
|
|
MBT
75
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
| $343K | 0.25% |
41,134
+8,875
| +28% | +$74K |
|